Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Diagnostic Tools of Waldenströms Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring.

Growkova K, Kufová Z, Sevcikova T, Filipová J, Kascak M, Jelínek T, Grosicki S, Barchnicka A, Roziaková Ľ, Mistrík M, Simicek M, Hájek R.

Klin Onkol. 2017 Summer;30(Supplementum2):81-91. doi: 10.14735/amko20172S81.

PMID:
28903575
2.

Whole Exome Sequencing of Aberrant Plasma Cells in a Patient with Multiple Myeloma Minimal Residual Disease.

Zatopkova M, Filipová J, Jelínek T, Vojta P, Sevcikova T, Simicek M, Rihova L, Bezdekova R, Growkova K, Kufová Z, Smejkalová J, Hajdúch M, Pour L, Minárik J, Jungová A, Maisnar V, Kryukov F, Hájek R.

Klin Onkol. 2017 Summer;30(Supplementum2):75-80. doi: 10.14735/amko20172S75.

PMID:
28903574
3.

Biomarkers in Immunoglobulin Light Chain Amyloidosis.

Kufová Z, Sevcikova T, Growkova K, Vojta P, Filipová J, Adam Z, Pour L, Penka M, Rysava R, Němec P, Brozova L, Vychytilova P, Jurczyszyn A, Grosicki S, Barchnicka A, Hajdúch M, Simicek M, Hájek R.

Klin Onkol. 2017 Summer;30(Supplementum2):60-67. doi: 10.14735/amko20172S60.

PMID:
28903572
4.

Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.

Growková K, Kryukova E, Kufová Z, Filipová J, Ševčíková T, Říhová L, Kaščák M, Kryukov F, Hájek R.

Eur J Haematol. 2017 Dec;99(6):469-478. doi: 10.1111/ejh.12959. Epub 2017 Oct 10. Review.

PMID:
28886236
5.

The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.

Mikulasova A, Wardell CP, Murison A, Boyle EM, Jackson GH, Smetana J, Kufova Z, Pour L, Sandecka V, Almasi M, Vsianska P, Gregora E, Kuglik P, Hajek R, Davies FE, Morgan GJ, Walker BA.

Haematologica. 2017 Sep;102(9):1617-1625. doi: 10.3324/haematol.2017.163766. Epub 2017 May 26.

6.

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies.

Ševčíková T, Growková K, Kufová Z, Filipová J, Vrublová P, Jelínek T, Kořístek Z, Kryukov F, Kryukova E, Hájek R.

J Clin Pathol. 2017 Oct;70(10):847-853. doi: 10.1136/jclinpath-2017-204329. Epub 2017 Mar 30.

7.

Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity.

Jelinek T, Kryukova E, Kufova Z, Kryukov F, Hajek R.

Hematol Oncol. 2017 Dec;35(4):408-419. doi: 10.1002/hon.2351. Epub 2016 Sep 20. Review.

PMID:
27647123
8.

Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview.

Kryukov F, Kryukova E, Brozova L, Kufova Z, Filipova J, Growkova K, Sevcikova T, Jarkovsky J, Hajek R.

Gene. 2016 Oct 15;591(2):490-8. doi: 10.1016/j.gene.2016.06.017. Epub 2016 Jun 7. Review.

PMID:
27288311
9.

Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.

Mikulasova A, Smetana J, Wayhelova M, Janyskova H, Sandecka V, Kufova Z, Almasi M, Jarkovsky J, Gregora E, Kessler P, Wrobel M, Walker BA, Wardell CP, Morgan GJ, Hajek R, Kuglik P.

Eur J Haematol. 2016 Dec;97(6):568-575. doi: 10.1111/ejh.12774. Epub 2016 Jun 9.

PMID:
27157252
10.

Immunomodulatory drugs in AL amyloidosis.

Jelinek T, Kufova Z, Hajek R.

Crit Rev Oncol Hematol. 2016 Mar;99:249-60. doi: 10.1016/j.critrevonc.2016.01.004. Epub 2016 Jan 15. Review.

PMID:
26806146
11.

Flow cytometry in immunoglobulin light chain amyloidosis: Short review.

Filipova J, Rihova L, Vsianska P, Kufova Z, Kryukova E, Kryukov F, Hajek R.

Leuk Res. 2015 Jul 13. pii: S0145-2126(15)30345-3. doi: 10.1016/j.leukres.2015.07.002. [Epub ahead of print] Review.

PMID:
26422558

Supplemental Content

Loading ...
Support Center